Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.
about
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentCrosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast CancerThe insulin-like growth factor system in cancerHeterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibodyEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor BInsulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma.IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances.Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancerInsulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.Function of RasGRP3 in the formation and progression of human breast cancerErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis.The mRNA expression of IGF-1 and IGF-1R in human breast cancer: association with clinico-pathological parameters.Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptorType I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cellsInsulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.Expression of IGF1R in normal breast tissue and subsequent risk of breast cancerThe impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.The role of the insulin-like growth factor-1 system in breast cancerDifferential expression of the insulin-like growth factor receptor among early breast cancer subtypes.Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situThe link between the metabolic syndrome and cancer.Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancerInsulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer.Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patientsRole of IGF-1 receptor in radiation response.Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform AExpression of nuclear insulin receptor substrate 1 in breast cancer.The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein BimBreast cancer: further metabolic-endocrine risk markers?Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
P2860
Q21195187-981EDEC7-E4DC-41B5-AA9B-724217A20F67Q24800144-3226E888-6857-4FCE-932C-6ACCFDBAA2DBQ26798408-9DDBA64E-FE7F-4B49-AA28-5F57A8A4FE08Q26860821-691478F6-8A0E-4218-B616-039A05E4A8B2Q27013945-9BFDDE2A-E86A-459B-9332-E56E78FDA3D8Q27306977-9666F492-252B-48F1-8F47-616C4BEA8430Q28087055-93B56F0F-E059-442A-B3EA-82AB7EC9EC7AQ30538044-AAEA446E-D1D0-441B-AF9C-ED7485F5F888Q31149390-444D6B1B-0394-4F0F-B09E-29CCCF469D35Q33522034-7ACA102F-069B-483F-AD0D-4FE0886781AAQ33586566-7B60A0A6-3977-4D63-A4D3-C91833C7503EQ33605369-A854D97B-470E-4154-8EBC-D6061EEFB104Q33842800-A9C179AC-CBBE-45C8-BDB7-FE2D562F6C54Q33875800-9C414546-7DB4-462C-96CB-E92BE91E8E83Q33934670-4CE3D875-A377-4FE1-86D6-72641BC7FDC9Q33960160-9FE18E44-77F9-47C0-817B-89D0558592BBQ34133760-1DEA27F0-57A1-4D4F-980C-CEB1E3C8A3DEQ34690787-52962511-1B3A-4C0B-8F81-C97F6AF26585Q34796287-A4806995-3D87-4AF4-9E84-F38B15AF12E8Q35012773-EB57AEA1-D74A-4BDC-8FF9-3CF05A2126AEQ35042972-D7773419-1F7C-4CFA-93D5-13DBE758CEC0Q35048307-6F852E71-6894-45F2-AA3C-0258411C2FCEQ35063782-577E7D8B-9065-484E-A9C8-06E26894D8E4Q35100621-FD404616-82A4-4101-AD4A-EBB3A1B1E03AQ35105295-07AE0307-B312-49F8-B6F7-8AB9ACAA744DQ35123145-A6557422-CBE6-4394-AADD-361B9471D16CQ35184951-850CF3ED-8CB2-4CF5-B0DE-3C5976DA8E63Q35187561-6B594B6F-47A3-489C-A399-A6135884DA22Q35192691-6435EAC9-0D23-4CBE-BC17-07F0F9B4CEE3Q35207321-40AFF91F-EF7B-4645-8F88-74D59CB31323Q35501973-B8B6B00F-7AEF-48CE-9E10-061AE327BDE2Q35586993-E25DEC26-A217-4FA0-9A8D-FA9FF03AA868Q35753837-9BB2A22C-8C7C-4654-A9AE-6AE9FCAC5367Q35762239-BA878363-A55D-43B9-9396-800464856039Q35879542-BE57E259-AFF7-47B5-A717-4008FC10C1C4Q35954427-1147DF2C-5AAA-42AD-8C16-49BEA90D031AQ36139739-C552F7E0-54A0-4137-AC9F-B315D7FA7CB8Q36245560-02DD905F-138D-474B-8EFD-F85EBF3C6B54Q36431629-6CD4A024-6DCE-44AE-9E0D-A0DFD23F0B3EQ36618874-E61F1E23-A838-4972-8B93-25836C539767
P2860
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@ast
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@en
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@nl
type
label
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@ast
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@en
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@nl
prefLabel
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@ast
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@en
Insulin-like growth factor-I r ...... w risk in human breast cancer.
@nl
P2093
P1433
P1476
Insulin-like growth factor-I r ...... ow risk in human breast cancer
@en
P2093
Fujita-Yamaguchi Y
Goldfine ID
McGuire WL
P304
P407
P577
1993-08-01T00:00:00Z